{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:28:25Z","timestamp":1752283705540,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As many people worldwide have been vaccinated, more triggered autoimmune bullous diseases have been noticed. We reported a case of new-onset pemphigus Vulgaris after COVID-19 vaccinations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 50\u00a0years old Syrian female presented with multiple erosions on her extremities, in addition to oral erosions and genital ulcers, after the 2nd dose of the mRNA COVID-19 vaccine. The lesions were multiple tenders and well-defined, reddish erythematous oral ulcers. At the same time the Skin examination showed hyper-pigmented patches over the extremities, a sequel of ruptured bullae. Pemphigus Vulgaris was diagnosed by histology. She continued on 35\u00a0mg\/day of prednisone for another 2\u00a0weeks.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Pemphigus is not a contraindication to vaccination, although it may be worse or present as a first onset.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04055-0","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T23:02:44Z","timestamp":1690412564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Naram","family":"Khalayli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-5011","authenticated-orcid":false,"given":"Abdullah","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayssoun","family":"Kudsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"4","key":"4055_CR1","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1111\/jdv.17868","volume":"36","author":"GV Knechtl","year":"2022","unstructured":"Knechtl GV, et al. Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient. J Eur Acad Dermatol Venereol. 2022;36(4):e251\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"14","key":"4055_CR2","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/jcm11143968","volume":"11","author":"X Huang","year":"2022","unstructured":"Huang X, et al. Pemphigus during the COVID-19 epidemic: infection risk, vaccine responses and management strategies. J Clin Med. 2022;11(14):3968.","journal-title":"J Clin Med"},{"issue":"10","key":"4055_CR3","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1111\/jdv.17480","volume":"35","author":"F Solimani","year":"2021","unstructured":"Solimani F, et al. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2. J Eur Acad Dermatol Venereol. 2021;35(10):e649\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"4055_CR4","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/odi.14034","volume":"28","author":"K Thongprasom","year":"2022","unstructured":"Thongprasom K, et al. Oral pemphigus after COVID-19 vaccination. Oral Dis. 2022;28(Suppl 2):2597\u20138.","journal-title":"Oral Dis"},{"issue":"Suppl 2","key":"4055_CR5","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1111\/odi.14089","volume":"28","author":"IG Koutlas","year":"2022","unstructured":"Koutlas IG, et al. Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine. Oral Dis. 2022;28(Suppl 2):2612\u20133.","journal-title":"Oral Dis"},{"issue":"6","key":"4055_CR6","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1111\/jocd.14945","volume":"21","author":"A Singh","year":"2022","unstructured":"Singh A, et al. Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature. J Cosmet Dermatol. 2022;21(6):2311\u20134.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"4055_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15396","volume":"35","author":"G Akoglu","year":"2022","unstructured":"Akoglu G. Pemphigus vulgaris after SARS-CoV-2 vaccination: a case with new-onset and two cases with severe aggravation. Dermatol Ther. 2022;35(5): e15396.","journal-title":"Dermatol Ther"},{"issue":"3","key":"4055_CR8","volume":"14","author":"F Hali Sr","year":"2022","unstructured":"Hali F Sr, et al. Autoimmune bullous dermatosis following COVID-19 vaccination: a series of five cases. Cureus. 2022;14(3): e23127.","journal-title":"Cureus"},{"issue":"1","key":"4055_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/ajd.13755","volume":"63","author":"ACY Lua","year":"2022","unstructured":"Lua ACY, et al. An unusual presentation of pemphigus foliaceus following COVID-19 vaccination. Australas J Dermatol. 2022;63(1):128\u201330.","journal-title":"Australas J Dermatol"},{"key":"4055_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153834","volume":"232","author":"E Calabria","year":"2022","unstructured":"Calabria E, et al. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: a Case report of Pemphigus Vulgaris and a literature review. Pathol Res Pract. 2022;232: 153834.","journal-title":"Pathol Res Pract"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04055-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T23:02:52Z","timestamp":1690412572000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04055-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4055"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04055-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"18 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was also taken from the faculty of medicine at Damascus University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}